CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$30.71
+0.49%Oct 19, 2026, 10:30 UTC
Caris Life Sciences, Inc. announced the launch of a national commercial promoting its Caris Detect multi-cancer early detection test, featuring Jordan Spieth.
Source:Oct 15, 2026, 12:30 UTC
Caris Life Sciences, Inc. announced that it will report its third-quarter 2026 financial results on November 4, 2026, and host a live webcast at 3:30 p.m.
Source:Oct 14, 2026, 12:30 UTC
Caris Life Sciences, Inc. announced that its researchers and the Caris Life Sciences, Inc. will present eight posters at the ESMO Congress 2026 in Madrid from October 23 to 27, 2026.
Source:Sep 8, 2026, 10:30 UTC
Caris Life Sciences launched a new national advertising campaign featuring Kevin Costner to promote early cancer detection and its Caris Detect blood test.
Source:Sep 2, 2026, 12:30 UTC
Caris Life Sciences announced it will present seven studies advancing precision oncology at the IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea.
Source:Aug 27, 2026, 14:59 UTC
Caris Life Sciences published a study in npj Precision Oncology describing the development and validation of its AI tool, Caris AI Insights, to guide first-line treatment choice for pancreatic cancer.
Source:Aug 5, 2026, 20:05 UTC
Caris Life Sciences reported second quarter 2026 financial results with total revenue of $263.7 million, a 45% increase over the prior year period, and raised its 2026 revenue guidance to $1.03 to $1.04 billion.
Jul 1, 2026, 12:30 UTC
Caris Life Sciences launched Caris Detect, a multi-cancer early detection blood test, in Irving, Texas.
Source:Jun 16, 2026, 12:30 UTC
Caris Life Sciences dual-listed its common stock on NYSE Texas, effective June 17, 2026, while maintaining its primary NASDAQ listing.
Source:Jun 8, 2026, 12:30 UTC
Caris Life Sciences announced a share repurchase program for up to $100 million of its common stock.
Source: